English | 简体中文 | 繁體中文 | 한국어
 All Press Releases
 Pharma & Biotech HealthCare & Pharma
Holista Signs Agreement with Costanzo's to Launch World's Lowest Glycaemic Index (GI) Clean Label Bread
Oct 01, 2020 15:00 HKT
Insumate(R)--Patented Peptide Sequence mcIRBP-19: a Boon for Diabetics Says Greenyn Biotechnology
Sep 28, 2020 16:00 HKT
노보텍 (Novotech), 파마 인텔리전스 (Pharma Intelligence)의 사이트라인 어워드 2020 (Citeline Awards 2020) 최종후보로 선정
Sep 28, 2020 14:00 HKT
APOLLOMICS(冠科美博)APL-106治療急性髓系白血病的III期臨床橋接研究獲得中國新藥臨床試驗批件
Sep 28, 2020 08:01 HKT
APOLLOMICS(冠科美博)APL-106治疗急性髓系白血病的III期临床桥接研究获得中国新药临床试验批件
Sep 28, 2020 08:00 HKT
애질렉스 바이오랩스, 세계에서 가장 정확한 칸나비노이드 분석법 개발
Sep 24, 2020 06:00 HKT
雅各臣就分拆品牌医疗保健业务递交上市申请表格(A1表格)
Sep 23, 2020 20:32 HKT
雅各臣就分拆品牌醫療保健業務遞交上市申請表格(A1表格)
Sep 23, 2020 20:31 HKT
Jacobson Pharma Submits Form A1 to Spin-off Its Branded Healthcare Business
Sep 23, 2020 20:30 HKT
Agilex Biolabs开发了世界上最准确的大麻素测定
Sep 23, 2020 13:00 HKT
Agilex Biolabs開發了世界上最準確的大麻素測定
Sep 23, 2020 13:00 HKT
Agilex Biolabs Develops World's Most Accurate Cannabinoid Assay
Sep 23, 2020 12:00 HKT
AIM ImmunoTech从荷兰鹿特丹伊拉斯姆斯大学医学中心 获得胰腺癌的统计学上显著的阳性存活结果
Sep 23, 2020 07:00 HKT
AIM ImmunoTech從荷蘭鹿特丹伊拉斯姆斯大學醫學中心 獲得胰腺癌的統計學上顯著的陽性存活結果
Sep 23, 2020 07:00 HKT
아방스 클리니컬, 바이오팜 아메리카에서 생명공학 임상시험을 위한 전자임상시험 솔루션 확대 발표
Sep 22, 2020 18:00 HKT
Avance Clinical宣布为美国BioPharm的生物技术临床试验研究 扩大电子临床解决方案
Sep 22, 2020 10:00 HKT
Avance Clinical宣佈為美國BioPharm的生物技術臨床試驗研究 擴大電子臨床解決方案
Sep 22, 2020 10:00 HKT
Avance Clinical Announces Expanded eClinical Solutions for Biotech Clinical Trials at BioPharm America
Sep 22, 2020 07:50 HKT
Impact BioMedical Demonstrates 10-Fold Reduction in Viral Population of COVID-19 in Surface Disinfectant Efficacy Testing of its 3F Antiviral Biofragrance
Sep 18, 2020 17:00 HKT
Dyadic宣布与江苏恒瑞医药合作开发生物药物
Sep 17, 2020 20:30 HKT
Next >>
Copyright © 2020 ACN Newswire - Asia Corporate News Network
Home | About us | Services | Partners | Events | Login | Contact us | Privacy Policy | Terms of Use | RSS
US: +1 800 291 0906 | Beijing: +86 10 8405 3688 | Hong Kong: +852 2217 2912 | Singapore: +65 6304 8926 | Tokyo: +81 3 5791 1818

Connect With us: